Teaching Clinic - Inflammatory bowel disease Flashcards

1
Q

What are environmental factors of IBD?

A
  • Infection
  • Antibiotics: gut microbiota alteration (dietary and bacterial antigens penetrate intestinal wall) and activate immune system to produce inflammation
  • Diet
  • Smoking
  • Stress
  • Drugs (NSAIDs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Crohns Disease vs Ulcerative Colitis
- Region of involvement
- Pattern of lesions

A

Crohns disease
* Affects mouth to anus and transmural involvement
* Regional enteritis: skip lesions
* Granulomatous enteritis: secondary to granulomas

Ulcerative colitis
* Affects colon and mucosal involvement (except in backwash ileitis)
* Continuous lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Crohns disease pattern of distribution in bowel?

A
  • Small bowel disease: 80%, with one-third ileitis only
  • 50% ileocolitis
  • 20% colon only
  • <5% mouth or gastroduodenal area
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Crohns disease common clinical features?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Crohns disease endoscopic features?

A

A. Early: apthous ulcers
B. Large ulcer interspersed with normal mucosa
C. Cobblestone appearance: nodular thickening, with linear or serpiginous ulcers
D. Stricture due to fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Other GI features of Crohns disease?

A

Phlegmon/ abscess
Perianal disease (skin tags, anal fissure, perirectal abscesses)
Malabsorption: bile salt malabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the ddx for crohns disease?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How to make dx of Crohns disease?

A

Avoid doing capsule endoscopy: if necessary then do barium meal through study first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What lab Ix for crohns disease?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the crohns disease activity index (CDAI)? (no need to remember)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are CD complications?

A

Fistula formation
Perforation/ abscess
Stricture/ SB obstruction
Nutrition deficiencies: Vit B12 (TI disease or resection)
Increased risk of adenoCA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the ulcerative colitis disease pattern?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SS of ulcerative colitis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ix for UC?

A
  • Clinical features (bloody diarrhea)
  • Laboratory studies
  • Endoscopy (colonoscopy)
  • Histology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Colonoscopy features of UC?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Histology of UC

A
  • Plasma cell infiltration
  • Lymphocytes,macrophages
  • Crypt abscess

No granuloma formation

17
Q

ddx for UC?

A

Infection: bacterial colitis (salmonella, shigella, campylobacter, Yersinia, E coli 0157:H7, C difficile); Amoeba
Non-infectious: Crohn’s disease, ischemic colitis, radiation colitis
Immunocompromised: CMV and HSV

18
Q

UC complications

A

Toxic megacolon: 15-50% mortality
Perforation
Cancer: increasing risk of dysplasia with increased time (except procitis). If proctitis only, then CA risks not increased.

19
Q

summary of clinical findings, colonoscopy, radiologic and histologic findings for UC vs crohns disease

A
20
Q

Extraintestinal manifestation of IBD

A

Arthritis: large joints, AS, sacroilitis
Uveitis, iritis, episcleritis
Erythema nodosum, pyoderma gangrenosum
Primary sclerosing cholangitis
Bone loss and osteoporosis
Vit B12 deficiency

21
Q

Mild IBD treatment

A
  • 5-ASA/ mesalamine: oral formula, suppository (preferred in rectal disease)
  • Antibiotics: metronidazole (anaerobic bacteria)
22
Q

Moderate to severe IBD treatment

A
  • Corticosteroids
  • Azathioprine and 6-mercaptopurine (purine analogs that inhibit T cell function): for maintenace. Action onset delay 3-6 months. Efficacy maintained up to 4 years post op. AE: pancreatitis, hepatotoxicity, bone marrow suppression
  • Infliximab and other TNF inhibitors

Not a routine to check TPMT

23
Q

AE to TNF inhibitors?

A
  • Infection, multiple sclerosis, lupus-like reactions are common to all anti-TNFs
  • Higher risk of common bacterial infections
  • TB and fungal infections
  • Before commencement (check HBsAg, QuantiFERON-TB Gold, CXR)
  • Treat abscess (antibiotics + drainage), withhold anti-TNF
24
Q

What is seen?

A

Toxic megacolon
Started in infliximab (check hep B, HIV, CMVp66 PCR (gancyclovir))